A tellurium-based cathepsin B inhibitor: Molecular structure, modelling, molecular docking and biological evaluation-Reference-Cited by-同舟云学术

A tellurium-based cathepsin B inhibitor: Molecular structure, modelling, molecular docking and biological evaluation

Published:2012-04 Issue: Volume:1013 Page:11-18
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Caracelli Ignez,Vega-Teijido Mauricio,Zukerman-Schpector Julio,Cezari Maria H.S.,Lopes José G.S.,Juliano Luiz,Santos Paulo S.,Comasseto João V.,Cunha Rodrigo L.O.R.,Tiekink Edward R.T.

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference95 articles.

1. Human and Parasitic Papain-Like Cysteine Proteases: Their Role in Physiology and Pathology and Recent Developments in Inhibitor Design

2. Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues

3. Insights into the Roles of Cathepsins in Antigen Processing and Presentation Revealed by Specific Inhibitors

4. Apoptotic Pathways: Involvement of Lysosomal Proteases

5. Cathepsin B Expression in Human Tumors

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of benzenesulfonamide containing 1,2,3-triazole and 1,3,4-oxadiazole hybrids as cathepsin B inhibitors and DFT calculations;Journal of Molecular Structure;2025-01

2. Ovicidal activity of diaryl dichalcogenides and ivermectin on Fasciola hepatica: A novel candidate for a blending-based therapeutic strategy;Acta Tropica;2024-10

3. Ovicidal Activity of Blending Diaryl Dichalcogenides and Ivermectin Against Fasciola Hepatica: An Alternative for Repurposing the Macrocyclic Lactones Group;2024

4. The Cytotoxicity of Tellurium Nanoparticles on Different Cell Lines and Their in vivo Anticancer Effects in an Animal Model;MIDDLE EAST J CANCER;2023

5. RECENTES AVANÇOS NA ADIÇÃO ELETROFÍLICA DE ORGANOCALCOGÊNIOS A ALQUENOS;Química Nova;2023